Literature DB >> 14519395

ADAMs: modulators of cell-cell and cell-matrix interactions.

Judith M White1.   

Abstract

ADAMs contain adhesive and metalloprotease domains. As major ectodomain sheddases, they release a variety of cell-surface proteins, including growth factors, cytokines, cell adhesion molecules and receptors. ADAMs can also cleave and remodel components of the extracellular matrix. Hence, ADAMs are emerging as key modulators of cell-cell and cell-matrix interactions. Important questions, including if and how ADAM adhesive domains promote ADAM protease function, are currently being addressed.

Mesh:

Substances:

Year:  2003        PMID: 14519395     DOI: 10.1016/j.ceb.2003.08.001

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN: 0955-0674            Impact factor:   8.382


  112 in total

Review 1.  Effect of NKG2D ligand expression on host immune responses.

Authors:  Marine Champsaur; Lewis L Lanier
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

2.  Role of a disintegrin and metalloprotease 10 in Staphylococcus aureus alpha-hemolysin-mediated cellular injury.

Authors:  Georgia A Wilke; Juliane Bubeck Wardenburg
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-12       Impact factor: 11.205

3.  Variability in melanoma metalloproteinase expression profiling.

Authors:  Orsi Giricz; Janelle L Lauer; Gregg B Fields
Journal:  J Biomol Tech       Date:  2010-12

4.  Z-DNA-forming silencer in the first exon regulates human ADAM-12 gene expression.

Authors:  Bimal K Ray; Srijita Dhar; Arvind Shakya; Alpana Ray
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-20       Impact factor: 11.205

5.  ADAM15 disintegrin is associated with aggressive prostate and breast cancer disease.

Authors:  Rainer Kuefer; Kathleen C Day; Celina G Kleer; Michael S Sabel; Matthias D Hofer; Sooryanarayana Varambally; Christoph S Zorn; Arul M Chinnaiyan; Mark A Rubin; Mark L Day
Journal:  Neoplasia       Date:  2006-04       Impact factor: 5.715

6.  ADAM12 and alpha9beta1 integrin are instrumental in human myogenic cell differentiation.

Authors:  Peggy Lafuste; Corinne Sonnet; Bénédicte Chazaud; Patrick A Dreyfus; Romain K Gherardi; Ulla M Wewer; François-Jérôme Authier
Journal:  Mol Biol Cell       Date:  2004-12-01       Impact factor: 4.138

7.  Apparent reduction of ADAM10 in scrapie-infected cultured cells and in the brains of scrapie-infected rodents.

Authors:  Cao Chen; Yan Lv; Bao-Yun Zhang; Jin Zhang; Qi Shi; Jing Wang; Chan Tian; Chen Gao; Kang Xiao; Ke Ren; Wei Zhou; Xiao-Ping Dong
Journal:  Mol Neurobiol       Date:  2014-04-26       Impact factor: 5.590

Review 8.  Profiling distinct mechanisms of tumour invasion for drug discovery: imaging adhesion, signalling and matrix turnover.

Authors:  Neil O Carragher
Journal:  Clin Exp Metastasis       Date:  2008-10-29       Impact factor: 5.150

9.  Expression of ADAM15 in lung carcinomas.

Authors:  A Schütz; W Härtig; M Wobus; J Grosche; Ch Wittekind; G Aust
Journal:  Virchows Arch       Date:  2005-03-09       Impact factor: 4.064

10.  ADAM22, a Kv1 channel-interacting protein, recruits membrane-associated guanylate kinases to juxtaparanodes of myelinated axons.

Authors:  Yasuhiro Ogawa; Juan Oses-Prieto; Moon Young Kim; Ido Horresh; Elior Peles; Alma L Burlingame; James S Trimmer; Dies Meijer; Matthew N Rasband
Journal:  J Neurosci       Date:  2010-01-20       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.